ProMetic Life Sciences Inc. | Cash Flow
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
17,398.00
2,576.00
56,785.00
110,669.00
120,036.00
237,896
Depreciation, Depletion & Amortization
869.00
1,694.00
2,437.00
3,250.00
4,576.00
Other Funds
2,904.00
20,010.00
3,953.00
26,173.00
46,411.00
Funds from Operations
5,416.00
24,465.00
44,341.00
95,473.00
102,414.00
Changes in Working Capital
11,787.00
1,283.00
969.00
1,851.00
20,120.00
Net Operating Cash Flow
17,203.00
25,748.00
45,310.00
97,324.00
122,534.00
Capital Expenditures
7,641.00
9,023.00
6,925.00
15,615.00
10,146.00
Sale of Fixed Assets & Businesses
-
-
-
13,495.00
-
Purchase/Sale of Investments
68.00
-
-
11,651.00
11,063.00
Net Investing Cash Flow
7,573.00
9,023.00
7,766.00
9,531.00
917.00
Issuance/Reduction of Debt, Net
6,560.00
3,564.00
-
-
3,454.00
Net Financing Cash Flow
41,208.00
44,416.00
54,802.00
86,938.00
117,615.00
Net Change in Cash
16,191.00
9,706.00
2,183.00
1,479.00
4,640.00
Free Cash Flow
24,133.00
33,712.00
51,035.00
111,409.00
130,222.00
Deferred Taxes & Investment Tax Credit
-
3,271.00
5,141.00
6,220.00
11,587.00
Net Assets from Acquisitions
-
-
841.00
-
-
Change in Capital Stock
31,744.00
27,970.00
58,755.00
60,765.00
74,658.00
Exchange Rate Effect
241.00
61.00
457.00
624.00
638.00
About ProMetic Life Sciences
View Profile
